Health
How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna – CNBC
Jennifer Doudna, 2020 Nobel Prize winner in chemistry for CRISPR gene editing and co-founder of Intellia Therapeutics, on future…
Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a medicine to a human body.
CRISPR, or clustered regularly interspaced short palindromic repeats, effectively cuts genomes and slices DNA…
Continue Reading
-
Noosa News7 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General18 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General21 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Business20 hours ago3 ASX 200 shares that could be top buys for growth
